Core function activities to provide assistance in protocol review, protocol development and activities associated with past, present, and future of the contraceptive clinical trials network (female…

Ended Awarded Last action

Contract number
75N94018F00005
Awardee
Awarding agency
Obligated
$516,723

Award facts

Contract value 100% obligated
$516,722.58 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 7 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
New York, NY 10032, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00005 · Nichd: R & D: pharmacokinetic/pharmacodynamic evaluation of levonorgestrel butanoate for female contraception: non-severable $4,653
Terminate for Convenience P00004 · EOI::defend the spend::EOI termination for convenience agreement $0
Other Administrative Action P00003 $77,294
Supplemental Agreement for work within scope P00002 $21,924
Supplemental Agreement for work within scope P00001 · Pharmacokinetic/pharmacodynamic evaluation of levonorgestrel butanoate for female contraception clinical trial $111,167
Original award $301,685

About this award

The National Institute of Child Health and Human Development (NICHD) awarded a cost-plus-no-fee delivery order valued at $516,723 to The Trustees of Columbia University in the City of New York (Health Sciences Division) on September 25, 2018, with completion targeted for July 14, 2026. This non-severable delivery order supports core function activities related to the Contraceptive Clinical Trials Network (CCTN), specifically providing protocol review, protocol development, and research and development services associated with pharmacokinetic and pharmacodynamic evaluation of levonorgestrel butanoate for female contraception. The work will be performed at Columbia University's location in New York, NY, with no small business set-aside designation applied to this award.

As a delivery order under an existing indefinite delivery vehicle, this contract leverages Columbia University's established research and clinical trial infrastructure to advance NICHD's contraceptive development objectives. The award reflects the institution's substantial capabilities in biomedical research, clinical investigation services, and translational medicine, which have positioned Columbia as a recurring federal research partner across the National Institutes of Health and other federal agencies. The cost-no-fee structure indicates reimbursement for direct costs incurred in executing protocol development and evaluation activities supporting the multi-site female contraceptive clinical trials network.

Description

Core function activities to provide assistance in protocol review, protocol development and activities associated with past, present, and future of the contraceptive clinical trials network (female sites) activities.

Quick answers

Who was awarded contract 75N94018F00005?

75N94018F00005 was awarded to The Trustees Of Columbia University In The City Of New York by National Institute of Child Health and Human Development (National Institutes of Health) on September 25, 2018.

How much is contract 75N94018F00005 worth?

The government has obligated $516,723 on 75N94018F00005.

Is contract 75N94018F00005 an order under another contract?

Yes. 75N94018F00005 is a delivery order under HHSN275201300010I, an indefinite delivery contract.

Was contract 75N94018F00005 competed?

The extent of competition for 75N94018F00005 was full and open competition. The government received 7 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award